- Report
- May 2025
- 196 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- April 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- June 2025
- 384 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- February 2025
- 182 Pages
Global
From €3426EUR$3,825USD£2,920GBP
€4031EUR$4,500USD£3,436GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1120EUR$1,250USD£954GBP
- Report
- July 2024
- 200 Pages
Global
From €4433EUR$4,949USD£3,779GBP
- Report
- May 2025
- 189 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 183 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 183 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 188 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 195 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 186 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- February 2025
- 300 Pages
Global
From €5329EUR$5,950USD£4,543GBP
- Report
- November 2024
- 150 Pages
Global
From €2911EUR$3,250USD£2,481GBP
€4344EUR$4,850USD£3,703GBP
- Report
- June 2025
- 372 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 197 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 651 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- February 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- July 2024
- 100 Pages
Global
From €3359EUR$3,750USD£2,863GBP
- Report
- January 2025
- 180 Pages
Global
From €3426EUR$3,825USD£2,920GBP
€4031EUR$4,500USD£3,436GBP

Catheter Related Bloodstream Infection (CRBSI) is a type of infection that occurs when a catheter is inserted into a patient's bloodstream. It is a serious complication that can lead to sepsis, organ failure, and even death. The risk of CRBSI increases with the duration of catheter use, and is more common in patients with weakened immune systems. To reduce the risk of CRBSI, catheters must be inserted and maintained properly, and the patient must be monitored for signs of infection.
The CRBSI market is composed of companies that develop and manufacture catheters, as well as those that provide infection prevention and control services. These companies are focused on providing products and services that reduce the risk of CRBSI and improve patient outcomes. Examples of companies in this market include Becton Dickinson, C.R. Bard, and Teleflex. Show Less Read more